Highlights of the second international symposium on genetic anticancer agents

Winald R. Gerritsen; Mark R.L. Krul

doi:10.1038/sj.cgt.7700378

Highlights of the second international symposium on genetic anticancer agents

Winald R. Gerritsen, Mark R.L. Krul

Research output: Contribution to journal › Article › peer-review

Abstract

This meeting truly provided all leading experts in the field of gene therapy excellent oppurtunities to present their most recent data and to discuss in depth current issues in this fast-moving field, from preclinical research to large phase III clinical trials. The succesful formula of this series will be continued in the Third International Symposium on Genetic Anticancer Agents, scheduled in Amsterdam, February 28-March 2, 2002.

Original language	English (US)
Pages (from-to)	678-680
Number of pages	3
Journal	Cancer Gene Therapy
Volume	8
Issue number	9
DOIs	https://doi.org/10.1038/sj.cgt.7700378
State	Published - 2001
Externally published	Yes

ASJC Scopus subject areas

Molecular Medicine
Molecular Biology
Cancer Research

Access to Document

10.1038/sj.cgt.7700378

Cite this

@article{9a7f407369954af4bbe2c714fd390583,

title = "Highlights of the second international symposium on genetic anticancer agents",

abstract = "This meeting truly provided all leading experts in the field of gene therapy excellent oppurtunities to present their most recent data and to discuss in depth current issues in this fast-moving field, from preclinical research to large phase III clinical trials. The succesful formula of this series will be continued in the Third International Symposium on Genetic Anticancer Agents, scheduled in Amsterdam, February 28-March 2, 2002.",

author = "Gerritsen, {Winald R.} and Krul, {Mark R.L.}",

year = "2001",

doi = "10.1038/sj.cgt.7700378",

language = "English (US)",

volume = "8",

pages = "678--680",

journal = "Cancer Gene Therapy",

issn = "0929-1903",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Highlights of the second international symposium on genetic anticancer agents

AU - Gerritsen, Winald R.

AU - Krul, Mark R.L.

PY - 2001

Y1 - 2001

N2 - This meeting truly provided all leading experts in the field of gene therapy excellent oppurtunities to present their most recent data and to discuss in depth current issues in this fast-moving field, from preclinical research to large phase III clinical trials. The succesful formula of this series will be continued in the Third International Symposium on Genetic Anticancer Agents, scheduled in Amsterdam, February 28-March 2, 2002.

AB - This meeting truly provided all leading experts in the field of gene therapy excellent oppurtunities to present their most recent data and to discuss in depth current issues in this fast-moving field, from preclinical research to large phase III clinical trials. The succesful formula of this series will be continued in the Third International Symposium on Genetic Anticancer Agents, scheduled in Amsterdam, February 28-March 2, 2002.

UR - http://www.scopus.com/inward/record.url?scp=0034804719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034804719&partnerID=8YFLogxK

U2 - 10.1038/sj.cgt.7700378

DO - 10.1038/sj.cgt.7700378

M3 - Article

C2 - 11593338

AN - SCOPUS:0034804719

SN - 0929-1903

VL - 8

SP - 678

EP - 680

JO - Cancer Gene Therapy

JF - Cancer Gene Therapy

IS - 9

ER -

Highlights of the second international symposium on genetic anticancer agents

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this